Artwork

محتوای ارائه شده توسط Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !

Gene Therapies: What’s to Come as The Industry Moves Forward

21:52
 
اشتراک گذاری
 

Manage episode 303986843 series 2991382
محتوای ارائه شده توسط Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

Welcome to Episode 1 of The Life Science Report. In this episode our host, Dr. Peter Bak, sits down with Brendan Wang and Kyle O’Neil of Back Bay Life Science Advisors to discuss the field of gene therapies and insights from their recently authored piece in Cell & Gene, “The Next Decade In Gene Therapy Innovation — 6 Critical Questions (And Answers),” and their newly released white paper on BBLSA.com.

Gene therapy has been talked about for many years, and it’s only in the past few years that we’ve begun to see some initial products make it to market. When many people think about gene therapies, they think they will be a curative treatment, but commercial positioning, pricing and the business model of gene therapies are still in flux.

Topics in this podcast include:

  • The scientific and commercial challenges of gene therapies
  • How the space is evolving from a commercial standpoint -The complicated issue of delivery
  • The investment of gene therapy & the outcome-based gene therapy business models
  • Risk-sharing agreements, payment methodologies & pricing models
  • The unfolding future of gene therapies

Cell & Gene guest column

Brendan Wang and Kyle O’Neil’s white paper on the Back Bay Life Science Advisors website.

Make sure to subscribe to The Life Science Report podcast and follow Back Bay Life Science Advisors on LinkedIn and Twitter. Thank you for joining us.

  continue reading

25 قسمت

Artwork
iconاشتراک گذاری
 
Manage episode 303986843 series 2991382
محتوای ارائه شده توسط Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

Welcome to Episode 1 of The Life Science Report. In this episode our host, Dr. Peter Bak, sits down with Brendan Wang and Kyle O’Neil of Back Bay Life Science Advisors to discuss the field of gene therapies and insights from their recently authored piece in Cell & Gene, “The Next Decade In Gene Therapy Innovation — 6 Critical Questions (And Answers),” and their newly released white paper on BBLSA.com.

Gene therapy has been talked about for many years, and it’s only in the past few years that we’ve begun to see some initial products make it to market. When many people think about gene therapies, they think they will be a curative treatment, but commercial positioning, pricing and the business model of gene therapies are still in flux.

Topics in this podcast include:

  • The scientific and commercial challenges of gene therapies
  • How the space is evolving from a commercial standpoint -The complicated issue of delivery
  • The investment of gene therapy & the outcome-based gene therapy business models
  • Risk-sharing agreements, payment methodologies & pricing models
  • The unfolding future of gene therapies

Cell & Gene guest column

Brendan Wang and Kyle O’Neil’s white paper on the Back Bay Life Science Advisors website.

Make sure to subscribe to The Life Science Report podcast and follow Back Bay Life Science Advisors on LinkedIn and Twitter. Thank you for joining us.

  continue reading

25 قسمت

همه قسمت ها

×
 
Loading …

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

 

راهنمای مرجع سریع